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Purpose: The conventional outflow pathway provides the primary source of resistance to aqueous humor drainage,
regulating intraocular pressure. Despite large pressure gradients across the inner wall of Schlemm’s canal (SC), cells
remain attached to their basement membrane. The goal of this study was to examine integrin-extracellular matrix binding
partners of the inner wall basement membrane that facilitate attachment.
Methods: Human outflow tissues and cultured cells were analyzed by immunofluorescence and western blotting,
respectively. Radial sections of human donor eyes or en face preparations of human SC inner wall were probed with
antibodies that specifically recognize collagens (Type I, III, and IV), laminins (LM-332 and LM-511) and laminin-specific
integrin subunits, α3, α6, β1, and β4, typical of vascular endothelia.
Results: Immunofluorescence studies showed collagens Type I and IV in the SC basement membrane but not collagen
III. As expected with mature vascular endothelia, SC cells in situ expressed LM-511 but not LM-332. Significantly, the
integrin α6 subunit was expressed uniquely by SC. En face labeling of the inner wall displayed integrin α6 colocalizing
with LM α5 at the cell periphery. Western blots of cultured human SC endothelial cell monolayers confirmed expression
of Type I collagen, collagen IV, LM-511, and the α6 integrin subunit. Interestingly, LM-332 was present in cultured SC
cells up to 60 days post-confluence.
Conclusions: Even though cells of the inner wall endure pressure gradients in the basal to apical direction, opposite of
other endothelia, human SC cells express basement membrane proteins and their cognate integrins typical of vascular
endothelia.
Elevated intraocular pressure (IOP) is a major risk factor
for the development of primary open-angle glaucoma
(POAG) [1]. In POAG, conventional outflow tissue
dysfunction causes increased resistance to aqueous humor
drainage, resulting in elevated IOP [2,3]. The principal
contributor to increased resistance in the conventional outflow
pathway remains unknown; however the location is likely in
the juxtacanalicular region of the trabecular meshwork, near
the inner wall of Schlemm's canal (SC) [3-9].
With its unique architecture and basal to apical direction
of flow, Schlemm's canal inner wall creates a dynamic
microenvironment for SC endothelial cells. Massive
mechanical loads and a discontinuous basement membrane
suggest the necessity of strong cell-matrix adhesion in
maintaining a continuous barrier to fluid flow [10,11]. Since
the strength of cellular adhesion is dependent on both
structural extracellular matrix (ECM) and integrins, it is
important to identify and understand their relationship at the
inner wall of Schlemm’s canal.
Mature vascular endothelial basement membranes
contain self-assembling lattices of collagen IV and
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laminin-511 connected by molecules of perlecan and nidogen
[12]. Additional structural proteins, such as tensile collagen I
and other laminins, are also incorporated into the basal lamina
[13]. The laminin expression profile of endothelia varies
during development and determines tissue function [14].
Endothelial cell integrins also play a large role in maintaining
cell-matrix adhesion. Vascular endothelial cells express
integrins α3β1, α6β1, and α6β4 to bind to laminin, while
collagen-specific integrins include α1β1 and α2β1 [15]. Since
SC inner wall endothelia share similarities with vascular
endothelia, perhaps SC cells express a similar pattern of
basement membrane and integrin proteins [16-18].
Previous attempts to identify extracellular matrix
proteins and integrins in Schlemm's canal basal lamina have
provided preliminary information [19-25]. However, some
studies used antibodies later shown to be non-specific. For
example, antibodies previously thought to identify
laminin-111 also bind laminin-511 and laminin-411. Recent
work with collagens and laminins has resulted in well
characterized and selective antibodies for cell-matrix
adhesion research.
In the present study, by examining the expression of
integrins, collagens and laminins in situ and in vitro, we
describe the major structural proteins of Schlemm's canal
basal lamina, identify a uniquely expressed integrin subunit
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by SC cells in the outflow pathway and define variations in
ECM expression caused by in vitro culture models.
METHODS
Human tissue: Post mortem enucleated eyes were obtained
from National Disease Research Interchange (NDRI;
Philadelphia, PA), the Life Legacy Foundation (Tucson, AZ)
and Sun Health Research Institute (Sun City, AZ), according
to the guidelines of the Declaration of Helsinki for research
involving human tissue. All tissue used was free of known
ocular disease and maintained in a humid chamber at 4 °C
until dissection.
SC cell culture: Human SC cells were isolated from donor
eyes using a cannulation technique developed in our
laboratory and cultured as previously described [26]. The cells
were maintained as stable monolayers in Dulbecco’s modified
Eagle’s medium (DMEM, low glucose; Invitrogen, Austin,
TX), supplemented with 10% fetal bovine serum, penicillin
(100 U/ml), streptomycin (0.1 mg/ml) and glutamine
(0.29 mg/ml; Life Technologies). Cells were used between
passages 2–5 and maintained at confluence for at least one
week before testing. Five different primary cell culture strains
(SC45, SC51, SC53, SC55, and SC56) were isolated from eye
donors (64, 66, 44, 29, and 29 years old, respectively) and
were used in experiments as available.
TM cell culture: Human TM cells were also isolated from
donor eyes, using a blunt dissection technique followed by
extracellular matrix digestion that was developed in our
laboratory [27]. The cells were brought to and maintained at
a stable monolayer using Dulbecco’s modified Eagle’s
medium (DMEM, low glucose), containing 10% fetal bovine
serum, penicillin (100 U/ml), streptomycin (0.1 mg/ml) and
glutamine (0.29 mg/ml). Upon reaching confluence, the fetal
bovine serum concentration was reduced to 1% and
maintained for at least a week until testing. Four different
primary cell culture strains (TM89, TM90, TM92, and TM93)
were isolated from donor eyes (64 years, 4 months, 38 years,
and 35 years old, respectively) and were used in experiments
as available.
Western blot: Media was removed from confluent monolayers
of SC and TM cells and rinsed with ice-cold phosphate-
buffered saline (PBS; Life Technologies). Cells were
mechanically scraped into ice-cold radio-
immunoprecipitation assay (RIPA) buffer (Sigma, St. Louis,
MO) with protease inhibitors (Complete Mini; Roche,
Indianapolis, IN), and chilled on ice for 10 min. The samples
were then centrifuged at 20,000× g for 8 min and the
supernatant removed, tested for total protein (BCA assay;
Pierce, Rockford, IL) and frozen at −80 °C. Lysates were
solubilized in Laemmli buffer or non-reducing buffer and
boiled for 10 min before fractionating proteins (10 μg total
protein/well) on SDS–PAGE gels (4%–15% gradient, 7.5%
or 10% non-gradient). Fractionated proteins were transferred
overnight onto nitrocellulose membranes by electrophoresis
at 21 V. The membranes were blocked with 5% non-fat dry
milk in Tris-buffered saline with 0.2% Tween-20 (TBS-T) and
probed with antibodies for western blot analysis (see Table 1
for a list of antibody conditions). After being rinsed four times
for 10 min in TBS-T, HRP-conjugated secondary antibodies
(Jackson Immunoresearch, West Grove, PA) were added.
Chemiluminescent substrate (HyGLO, Denville or
ADVANCE; Pierce) was added to the membranes
immediately before exposure to X-ray film (Genesee, San
Diego, CA).
Confocal immunofluorescence microscopy: Radial wedges
excised from the anterior segments of fresh human post
mortem eyes were frozen in optimal cutting temperature
compound (OCT; Sakura, Torrance, CA). The tissue was
sectioned (6.5 μm) radially and fixed for 10 min in ice-cold
acetone. The slides were incubated for 30 min in the following
antibodies diluted in PBS: anti-collagen Type I (Biogenesis/
AbD Serotec, Raleigh, NC), anti-collagen III (Biogenesis
TABLE 1. ANTIBODIES USED FOR WESTERN BLOTTING.
Antibody Dilution Clone/catalog Gel conditions
Collagen I 1:5,000 Anti-CN1 LB
Collagen IV 1:1,000 IV-4H122 NRB
Laminin α3 1:1,000 BM1656 LB
Laminin α5 1:1,000 sc-201454 LB
Laminin β3 1:1,000 sc-55834 LB
Laminin γ1 1:500 Clone 175 LB
Laminin γ2 1:1,000 2E83 LB
Integrin α1 1:500 FB123 NRB
Integrin α2 1:1,000 AB19363 LB
Integrin α3/α6 1:10,000 AA6A7 NRB
        1Immunohistochemical research (Gilbertsville, PA). 2Calbiochem (San Diego, CA). 3Millipore (Billerica, MA). 4Santa Cruz
        Biotechnologies (Santa Cruz, CA). 5BD Biosciences (Franklin Lakes, NJ). 6BM165; Dr. Robert Burgeson, Harvard University,
        Cambridge, MA and Dr. Peter Marinkovich, Stanford University, Palo Alto, CA, 7Clone 4C7; Millipore, Billerica, MA. In the
        table, NRB indicates non-reducing buffer and LB indicates Laemmli buffer.
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Labs and Abcam, Cambridge, MA), anti-collagen IV alpha 1
(Clone H11; gift of Dr. Yoshikazu Sado, Shigei Medical
Research Institute, Japan), anti-integrin alpha 6 (JIB5;
Caroline Damsky, Department of Cell and Tissue Biology,
UC San Francisco, San Francisco, CA), anti-integrin alpha 3
(P1B5; Millipore, Billerica, MA), anti-integrin beta 1 (P4G11,
Chemicon), anti-integrin beta 4 (Chemicon), anti-laminin
alpha 3 (BM165; Dr. Robert Burgeson, Harvard University,
Cambridge, MA and Dr. Peter Marinkovich, Stanford
University, Palo Alto, CA), anti-laminin alpha 4 (FC10;
generated by Dr. Artturi Virtanen, University of Helsinki,
Finland), or anti-laminin alpha 5 (Clone 4C7; Millipore). The
slides were then rinsed three times for 5 min in PBS before
incubation with secondary antibodies (Alexa-Fluor 488 goat
anti-mouse, goat anti-rabbit, or goat anti-rat) for 30 min. The
slides were washed once more and then mounted and viewed
with a confocal microscope (Zeiss 7700L, Carl Zeiss, Inc,
Thornwood, NY). We evaluated background labeling and
tissue autofluorescence by incubation of tissue sections with
secondary antibodies alone and imaging under identical
conditions as the experimental samples.
Immunoprecipitation: Confluent monolayers of SC or TM
cells were rinsed in ice-cold PBS and then mechanically
scraped into ice-cold RIPA buffer and centrifuged, as
described before. In parallel, protein G beads (Immunopure;
Pierce) were washed with RIPA buffer. Solubilized cell
supernatants were pre-cleared with an aliquot of washed beads
for 1 h at 4 °C with rotation. Aliquots of cell supernatants
(100 μg total protein) were used for each
immunoprecipitation. Antibodies (1 μg) were added to each
samples and rotated for 1 h at 4 °C. Upon addition of the beads,
the sample + antibody + bead solution was rotated at 4 °C
overnight. Antibody complexes were isolated by
centrifugation at 6,000× g for 1 min. After removing
supernatant, the beads were washed three times (500 μl) with
ice-cold RIPA buffer before loading buffer (40 μl) was added
to the beads. After boiling at 100 °C for 10 min and
centrifugation at 6,000× g for one min, the supernatants were
analyzed by SDS–PAGE and western blotting as described
before. Reverse co-immunoprecipitations for laminin-511
were performed to determine whether laminin subunits
assembled. The antibody pair used was laminin α5 (sc-20145)
and laminin γ1 (2E8). In addition, immunoprecipitation to
specifically detect integrin α6 in SC and TM cells used
integrin α6 antibody (J1B5) as the pull-down antibody and
integrin α3/α6 antibody (AA6A) to probe.
En face labeling: Human eyes were obtained from the Eye
Bank of Canada (Ontario Division, Toronto, Canada) and
stored in moistened chambers at 4 °C before use. To preserve
outflow structures, eyes were perfused using standard
methods [28] and fixed under pressure (8 mmHg) by anterior
chamber exchange with 3% formalin in PBS and perfused for
a further 30 min. They were then removed from the system,
hemisected and the outflow tissue cut into wedges and stored
in 15% glycerol in PBS at −20 °C. Radial segments of the
limbal area were microdissected using a modification of
previously described techniques [29,30]. Briefly, the TM and
adherent inner wall of SC were carefully folded anteriorly.
This procedure opened SC like a book (with the book spine
analogous to the anterior margin of the canal) allowing en-
face visualization of both the inner and outer wall endothelia.
Tissue was permeabilized in cold acetone for 10 min and
blocked with 10% goat serum (Sigma)/10% donkey serum
(Jackson Immunoresearch) in PBS, for 30 min at room
temperature. The inner wall and underlying TM were labeled
with antibodies to visualize laminin α5, integrin α6, CD31 and
nuclei. Laminin α5 was labeled with rabbit anti-Laminin α5
IgG (Santa Cruz Biotechnology, Santa Cruz, CA) diluted 1:50
in PBS and incubated overnight at 4 ⁰C, followed by
incubation in Alexa-647 goat anti-rabbit IgG (Invitrogen,
Austin, TX) diluted 1:150 for 3 h. Integrin α6 was labeled with
rat anti-Integrin α6 (gift of Damsky Lab) diluted 1:50 in dPBS
and incubated overnight at 4 °C, followed by incubation in
Cy3 goat anti-rat IgG (Abcam, Cambridge, MA) diluted 1:100
in dPBS, for 3 h at RT. CD31 was labeled with mouse anti-
CD31 (DAKO, Glostrup, Denmark) in dPBS and incubated
overnight at 4 °C, followed by incubation in Cy2 donkey anti-
mouse IgG (Jackson Immunoresearch), diluted 1:100, for 3 h
at RT. For negative controls, tissue was treated as above while
excluding the primary antibodies. Nuclei were stained by
incubation for 5 min at RT in DAPI (Invitrogen, Austin, TX)
diluted at 2 µg/ml in PBS. Samples were examined using a
Zeiss LSM 510 meta confocal microscope (Carl Zeiss Inc.,
Jena, Germany). Images were viewed using Zeiss LSM Image
Browser version 4.2 (Carl Zeiss Inc.).
RESULTS
To better understand the mechanisms by which cells of
Schlemm’s canal (SC) inner wall withstand pressure gradients
in the basal to apical direction and remain adherent to their
basement membrane, we examined expression levels of key
matrix and adhesion proteins by Schlemm’s canal endothelia
(vascular endothelial cadherin labeling marks SC; Figure 1A).
We found that a primary structural component of the
extracellular matrix, type I collagen, was a prominent
component of SC inner wall basement membrane in situ as
well as in the TM (Figure 1A). Similarly, we observed
collagen IV, present in all basement membranes in the
conventional outflow pathway, including SC’s inner wall
(Figure 1A). We were unable to detect type III collagen in
outflow pathway tissues, but did see positive staining in
human crystalline lens capsule (data not shown). Both type I
and type IV collagen were produced by mature monolayers of
SC and TM cells in culture. Type I collagen in vitro was
represented by multiple bands due to post-translational
modifications and protein solubility (Figure 1B). While the
production of collagen I was similar between SC and TM cells,
collagen IV production was much greater in TM cells.
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Laminin-511 is the dominant laminin type expressed by
both SC, including at the inner wall, and TM tissues in situ
(α5; Figure 2A). In contrast, we were unable to detect
laminin-332 in the conventional tract (α3; Figure 2A).
Positive staining with laminin-332 antibodies was observed
in human prostate tissue (data not shown). We looked at these
two laminins in vitro and confirmed that cultured SC and TM
cell monolayers produced laminin-511 (α5 and β1). To verify
Figure 1. Collagens in human
conventional outflow pathway and
cultured cells. A: Confocal
immunofluorescence microscopy of
outflow tissues from cadaveric human
eyes examining the expression levels of
collagen (CN) I, III, and IV. Vascular
endothelial cadherin (VE-cad) labeling
was used as positive control for integrity
of tissue antigens and localization of
Schlemm’s canal (SC). Shown are
representative images taken from
section of one donor eye of 3 examined.
B: Western blot analysis of collagen
levels in different strains of cultured
human trabecular meshwork (TM) and
SC cell monolayers isolated from
different individual eye donors. Anti-
collagen I IgGs recognized multiple
bands between 140 and 40 kDa,
corresponding to post-translational
modifications.
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that subunits were being assembled into heterotrimers, co-
immunoprecipitation assays were executed, pulling down
protein complexes with antibodies that recognize the γ1
laminin subunit and probing blots with anti-α5 antibodies
(Figure 2B). Interestingly, we observed that both outflow cell
types also produce laminin-332 (β3; Figure 2B) with SC
producing noticeably more even in cell monolayers confluent
for 8 weeks.
To investigate the integrin pairs, namely α1β1, α2β1,
α3β1, α6β1 and α6β4, that may be mediating adhesion of SC
to its basal lamina, we examined human tissue and cells for
expression levels of individual integrin subunits. The
promiscuous integrin-β1 and collagen-specific integrin-α2
were abundantly expressed by both TM and SC cells in situ
(Figure 3A) and in vitro (Figure 3B), respectively. With
respect to laminin-specific subunits, we found α3, α6, and β4
in conventional outflow pathway tissues (Figure 3A and
Figure 4A). Expression was confirmed for integrin α3/α6 in
cultured cell monolayers, showing similar expression levels
between SC and TM cells (Figure 3B). In contrast, we
observed that integrin α6 was uniquely expressed by
Schlemm’s canal in the outflow tract in situ (Figure 4A) and
by scleral blood vessels. We confirmed the restricted
expression pattern of integrin α6 in cultured SC cell
monolayers (Figure 4B), not detecting expression by TM
cells.
To examine the relationship between integrin α6 and
laminin α5, we performed en face confocal imaging of the
inner wall of SC that was probed with antibodies specific for
integrin α6, laminin α5 and CD31. We used the endothelial-
Figure 2. Laminins-332 and −511 in
human conventional outflow pathway
and cultured cells. A: Confocal
immunofluorescence microscopy of
endothelial laminins (LM) in radial
sections through human conventional
outflow tissues. Shown are
representative images taken from one
human donor eye of three that were
examined. B: western blot analysis of
endothelial laminin levels by different
strains of cultured SC and TM cell
monolayers isolated from different
individual eye donors. Samples for
laminin α5 blots were obtained after cell
lysates were first immunoprecipitated
with anti-laminin γ1 IgGs.
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Figure 3. Vascular endothelial integrins
in human conventional outflow pathway
and cultured cells. A: Confocal
immunofluorescence microscopy of
outflow tissues from human, post-
mortem eyes examining integrin
(INTG) subunit levels. Shown are
results obtained from one eye from one
individual donor of three total that were
examined. Background fluorescence in
the absence of primary antibodies is
shown (2°). B: western blot analysis of
integrin levels by different human
Schlemm’s canal (SC) and trabecular
meshwork (TM) cell strains in culture.
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specific marker, CD31, to locate SC endothelial cells and
simultaneously captured fluorescent signals from the other
two proteins. We observed that integrin α6 displayed a
perinuclear distribution that extended to cell borders (Figure
Figure 4. Integrin α6 subunit expression
by Schlemm’s canal cells. A: Confocal
immunofluorescence microscopy of
outflow tissues including Schlemm’s
canal (SC) from human donor eyes
showing α6 integrin (INTG) levels.
Shown is representative image from eye
of individual human donor of 3 donor
eyes that were examined. For
comparison, a scleral vessel is indicated
(*). B: western blot analysis of different
human SC and trabecular meshwork
(TM) cell strains checking for α6
integrin levels. Cell lysates were first
subjected to immunoprecipition using
integrin α6-specific IgGs, followed by
SDS–PAGE and western blotting using
IgGs that recognize both α3 and α6
INTG.
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5A). Laminin α5 appeared as a distinct pattern of labeling over
the field of view with openings that roughly corresponded to
cell nuclei (Figure 5B). The merged image (Figure 5D) shows
that integrin α6 co-localized with CD31 on the cell surface,
but extended further to the cell periphery, where laminin α5
and integrin α6 appeared to colocalize.
DISCUSSION
In the present study we examined the expression of collagens,
laminins and their cognant integrin receptors, describing the
major structural proteins of human Schlemm's canal (SC)
basal lamina in situ and in cultured human SC monolayers in
vitro. We identified collagen I, IV, and laminin-511 as
prominent structural proteins in the SC basal lamina plus the
integrin subunits, α2, α3, α6, β1, and β4. Significantly, we
found that α6 was uniquely expressed by SC cells in situ in
the conventional outflow tract and in vitro by cultured SC
cells, representing a novel cell marker. Moreover, in
colocalization studies we observed that laminin-511 and
integrin α6 expression overlapped at the cell periphery of SC,
coincident with regions of the inner wall displaying high
adhesive strength in vivo.
Collagens: With a triple helix made of post-
translationally modified monomers, type I collagen fibrils are
able to extend indefinitely and provide tremendous tensile
strength. Numerous studies have established the presence of
collagen I in ocular tissues, including SC and TM [31]. Our
in situ results are similar to results found previously [19,21,
25,32-37] and are supported for the first time by in vitro data
with cultured human SC cell monolayers. Another collagen in
vascular basal lamina is collagen IV, a basement membrane-
specific lattice collagen [38]. The stability of the collagen IV
lattice provides considerable structural integrity to the basal
lamina and allows the matrix to compensate for mechanical
strain [12]. A previous study found collagen IV in outflow
tissues by probing at an ultrastructural level [21]. We
Figure 5. En face confocal immunofluorescence microscopy of Schlemm’s canal inner wall. Shown is labeling of the inner wall of SC (viewed
from luminal side) for integrin α6 (A, green), laminin α5 (B, red), CD31 (C, blue). Panel D is a merged image of all three proteins plus nuclei
(brown). Shown is representative image from a human donor eye of 6 total eyes that were examined.
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confirmed collagen IV expression in situ in the basal lamina
of Schlemm’s canal and showed that SC cells produce
collagen IV in vitro, but not to the same extent as TM cells.
The abundant expression of collagen IV by TM cells in culture
may be reflective of their role in vivo in maintaining an
extensive network of lamellar beams in the conventional
outflow tract [32,33] or may be a function of cell culture
conditions.
Laminins: Laminin proteins are currently known by the
shorthand “LM” followed by a numeric corresponding to the
alpha, beta, and gamma chains of the heterotrimeric molecule
[39]. For example, laminin-5, also known as kalinin, is
referred to as laminin-332 and laminin-10 is called
laminin-511. Identifying laminin subunits has gotten better
with more specific antibodies. For instance, antibodies
previously thought specific for laminin α1, only expressed in
laminin-111 (LM-1) and laminin-121 (LM-3), have been
found to also recognize laminin α5, present in both
laminin-511 and laminin-521 (LM-11). Antibodies currently
available, including those used in the present study, are more
selective for individual monomers.
Recently, laminin research has undergone a major shift
concerning the role of laminin in the ECM and the
identification of laminin subunits [15,40,41]. As a required
part of basement membranes, laminins have shifted from
being viewed as structural scaffolding to being hailed as a
determinant in tissue function with various isoforms found to
be cell and tissue specific. Moreover, their spatial and
temporal specificity has been determined to affect tissue
functionality. For example, laminin-332 is expressed by
endothelial cells during early development and angiogenesis
[42]. Upon establishing a mature vasculature, the expression
of laminin subunits in vivo shifts to LM-511 [43]. While
integrin-receptor pairs have not been uniquely identified for
every laminin heterotrimer, a change from LM-332 to
LM-511 expression roughly corresponds to integrin subunit
expression shift from integrin α3 to α6 [44]. The observed α6
integrin expression in situ and in vitro by SC suggests that SC
cells in culture have begun to differentiate, preparing for a
LM-511 containing basement membrane.
Our studies support the premise that laminin expression
varies based upon functionality and developmental stage. For
example, we show that laminin-511, but not laminin-332 is
expressed in situ in human outflow tissues. In contrast, we
observed in vitro that both the “immature” (laminin-332) and
“mature” (laminin-511) proteins were produced by cultured
SC and TM cell monolayers. Even though we differentiate
cells in culture for two weeks at confluence, clearly they are
still in an angiogenic state based upon their secretion profile.
As a control, we tested human umbilical vein endothelial cell
monolayers, and observed that they also expressed both
laminin-332 and laminin-511 at confluence (data not shown).
Integrins: Integrin heterodimers are composed of two
subunits (α and β), connected by covalent bonds. The integrin
heterodimers connect the cell cytoskeleton to the ECM,
facilitating signal transduction and affecting cell function
[15]. Selectivity of binding to the ECM is dependent upon
combination of the two subunits [45]. For example, while β1
is a widely expressed subunit, it may be involved in laminin
or collagen binding, depending upon the α subunit with which
it complexes. For example integrin α1β1 and α2β1 both
interact with collagen polymers, while the integrin
heterodimers α3β1 and α6β1 are specific to laminins.
Interestingly, integrin α6β1 binds selectively to laminin-511
[44]. In the present study, not surprisingly, we found that both
TM and SC cells express the collagen-binding integrin α2 and
laminin-binding integrin, α3. In contrast, SC cells both in situ
and in vitro uniquely expressed integrin α6. We were fortunate
to have a blood vessel present in most of our tissue sections
as an internal positive control, confirming the known
expression pattern of vascular endothelial integrins (i.e.:
α3β1, α6β1, and α6β4) [43,46-48]. Our results are in
agreement with the vasculature literature, but different from
another study [24] that did not find integrin β4 in SC, likely
due to differences in available antibodies.
To examine the potential relationship between integrin
α6 (α6β1) and laminin-α5 (511) at the level of the SC
basement membrane, we employed en face imaging of the
inner wall of SC from human eyes. This technique allows
simultaneous capture of fluorescent signals from 4 sources
(integrin α6, laminin-α5, CD31 and nuclei) from the luminal
surface of an intact inner wall [29,30]. In our studies we
observed co-localization between laminin α5 and integrin α6
at the periphery of SC cells. These data are consistent with the
idea that this particular integrin-laminin interaction provides
adhesive support to secure SC cells to their basement
membrane in opposition to basal to apical flow across the
endothelia. Significantly, the cell periphery, near sites of cell-
cell adhesions are often anchor points for SC cells that have
lifted off of their basement membrane, forming “giant
vacuoles” in the face of flow. To better understand the role of
integrin-laminin adhesion in giant vacuole formation, it would
be interesting to examine inner wall regions that experience
high flow compared to low flow for differences in localization
and/or expression of integrin-laminin pairs in future studies.
ACKNOWLEDGMENTS
The authors thank Emely Hoffman for providing human
trabecular meshwork cells plus Dr. Sangita Pawar, Dr. Brian
McKay, and Jaime Gard for helpful discussions.
Immunohistochemical data generated by Kathy McDaniel in
the TACMASS Core (Tissue Acquisition and Cellular/
Molecular Analysis Shared Service) is supported by the
Arizona Cancer Center Core Grant, NIH CA023074. Other
funding sources are: NIH, EY12797 and EY17007 (W.D.S.),
American Health Assistance Foundation (D.R.O.),
Cardiovascular Training Grant HL007955 (S.S.V.).
Molecular Vision 2011; 17:199-209 <http://www.molvis.org/molvis/v17/a24> © 2011 Molecular Vision
207
REFERENCES
1. Epstein D, Allingham R, Schuman J, editors. Chandler and
Grant's, Glaucoma, 4th ed., Baltimore: Williams and Wilkins;
1997.
2. Grant WM. Clinical tonography. Trans Am Acad Ophthalmol
Otolaryngol 1951; 55:774-81. [PMID: 14893332]
3. Grant WM. Experimental aqueous perfusion in enucleated
human eyes. Arch Ophthalmol 1963; 69:783-801. [PMID:
13949877]
4. Bahler CK, Hann C, Fautsch M, Johnson D. Pharmacological
disruption of Schlemm's canal cells and outflow facility in
anterior segments of human eyes. Invest Ophthalmol Vis Sci
2004; 45:2246-54. [PMID: 15223802]
5. Ethier CR, Chan D. Cationic ferritin changes outflow facility
whereas anionic ferritin does not. Invest Ophthalmol Vis Sci
2001; 42:1795-802. [PMID: 11431444]
6. Johnson M, Shapiro A, Ethier CR, Kamm RD. Modulation of
outflow resistance by the pores of the inner wall endothelium.
Invest Ophthalmol Vis Sci 1992; 33:1670-5. [PMID:
1559767]
7. Mäepa O, Bill A. Pressures in the juxtacanalicular tissue and
Schlemm's canal in monkeys. Exp Eye Res 1992;
54:879-83. [PMID: 1521580]
8. Rosenquist R, Epstein DL, Melamed S, Johnson M, Grant WM.
Outflow resistance of enucleated human eyes at two different
perfusion pressures and different extents of trabeculectomy.
Curr Eye Res 1989; 8:1233-40. [PMID: 2627793]
9. Overby DR, Stamer WD, Johnson M. The changing paradigm
of outflow resistance generation: towards synergistic models
of the JCT and inner wall endothelium. Exp Eye Res 2009;
88:656-70. [PMID: 19103197]
10. Johnstone MA. Pressure-dependent changes in nuclei and the
process origins of the endothelial cells lining Schlemm's
canal. Invest Ophthalmol Vis Sci 1979; 18:44-51. [PMID:
103860]
11. Johnstone MA, Grant M. Pressure-dependent changes in
structures of the aqueous outflow system of human and
monkey eyes. Am J Ophthalmol 1973; 75:365-83. [PMID:
4633234]
12. LeBleu VS, Macdonald B, Kalluri R. Structure and function of
basement membranes. Exp Biol Med (Maywood) 2007;
232:1121-9. [PMID: 17895520]
13. Ekblom M, Falk M, Salmivirta K, Durbeej M, Ekblom P.
Laminin isoforms and epithelial development. Ann N Y Acad
Sci 1998; 857:194-211. [PMID: 9917842]
14. Kruegel J, Miosge N. Basement membrane components are key
players in specialized extracellular matrices. Cell Mol Life
Sci 2010; 67:2879-95. [PMID: 20428923]
15. Schwartz MA, Ingber DE. Integrating with integrins. Mol Biol
Cell 1994; 5:389-93. [PMID: 8054683]
16. Heimark RL, Kaochar S, Stamer W. Human Schlemm's canal
cells express the endothelial adherens proteins, VE-cadherin
and PECAM-1. Curr Eye Res 2002; 25:299-308. [PMID:
12658549]
17. Ramos RF, Hoying JB, Witte MH, Daniel Stamer W.
Schlemm's canal endothelia, lymphatic, or blood vasculature?
J Glaucoma 2007; 16:391-405. [PMID: 17571003]
18. Hamanaka T, Bill A, Ichinohasama R, Ishida T. Aspects of the
development of Schlemm's canal. Exp Eye Res 1992;
55:479-88. [PMID: 1426078]
19. Brilakis HS, Hann CR, Johnson DH. A comparison of different
embedding media on the ultrastructure of the trabecular
meshwork. Curr Eye Res 2001; 22:235-44. [PMID:
11462161]
20. Dietlein TS, Jacobi PC, Paulsson M, Smyth N, Krieglstein GK.
Laminin heterogeneity around Schlemm's canal in normal
humans and glaucoma patients. Ophthalmic Res 1998;
30:380-7. [PMID: 9731120]
21. Hann CR, Springett MJ, Wang X, Johnson DH. Ultrastructural
localization of collagen IV, fibronectin, and laminin in the
trabecular meshwork of normal and glaucomatous eyes.
Ophthalmic Res 2001; 33:314-24. [PMID: 11721183]
22. Lütjen-Drecoll E, Rittig M, Rauterberg J, Jander R,
Mollenhauer J. Immunomicroscopical study of type VI
collagen in the trabecular meshwork of normal and
glaucomatous eyes. Exp Eye Res 1989; 48:139-47. [PMID:
2920781]
23. Marshall GE, Konstas AG, Lee WR. Immunogold localization
of type IV collagen and laminin in the aging human outflow
system. Exp Eye Res 1990; 51:691-9. [PMID: 2265680]
24. Tervo K, Paallysaho T, Virtanen I, Tervo T. Integrins in human
anterior chamber angle. Graefes Arch Clin Exp Ophthalmol
1995; 233:291-5. [PMID: 7622078]
25. Marshall GE, Konstas AG, Lee WR. Collagens in ocular tissues.
Br J Ophthalmol 1993; 77:515-24. [PMID: 8025051]
26. Stamer WD, Roberts BC, Howell DN, Epstein DL. Isolation,
culture and characterization of endothelial cells from
Schlemm's canal. Invest Ophthalmol Vis Sci 1998;
39:1804-12. [PMID: 9727403]
27. Stamer WD, Seftor R, Williams S, Samaha H, Snyder R.
Isolation and culture of human trabecular meshwork cells by
extracellular matrix digestion. Curr Eye Res 1995;
14:611-7. [PMID: 7587308]
28. Ethier CR, Ajersch P, Pirog R. An improved ocular perfusion
system. Curr Eye Res 1993; 12:765-70. [PMID: 8222738]
29. Read AT, Chan DW, Ethier CR. Actin structure in the outflow
tract of normal and glaucomatous eyes. Exp Eye Res 2006;
82:974-85. [PMID: 16325178]
30. Stamer WD, Read AT, Sumida GM, Ethier CR. Sphingosine-1-
phosphate effects on the inner wall of Schlemm's canal and
outflow facility in perfused human eyes. Exp Eye Res 2009;
89:980-8. [PMID: 19715693]
31. Timpl R. Structure and biological activity of basement
membrane proteins. Eur J Biochem 1989; 180:487-502.
[PMID: 2653817]
32. Acott TS, Kelley MJ. Extracellular matrix in the trabecular
meshwork. Exp Eye Res 2008; 86:543-61. [PMID:
18313051]
33. Yue BY. The extracellular matrix and its modulation in the
trabecular meshwork. Surv Ophthalmol 1996; 40:379-90.
[PMID: 8779084]
34. Filla MS, David G, Weinreb RN, Kaufman PL, Peters DM.
Distribution of syndecans 1–4 within the anterior segment of
the human eye: expression of a variant syndecan-3 and
matrix-associated syndecan-2. Exp Eye Res 2004; 79:61-74.
[PMID: 15183101]
Molecular Vision 2011; 17:199-209 <http://www.molvis.org/molvis/v17/a24> © 2011 Molecular Vision
208
35. Fuchshofer R, Welge-Lussen U, Lutjen-Drecoll E, Birke M.
Biochemical and morphological analysis of basement
membrane component expression in corneoscleral and
cribriform human trabecular meshwork cells. Invest
Ophthalmol Vis Sci 2006; 47:794-801. [PMID: 16505009]
36. Kabosova A, Azar DT, Bannikov GA, Campbell KP, Durbeej
M, Ghohestani RF, Jones JC, Kenney MC, Koch M,
Ninomiya Y, Patton BL, Paulsson M, Sado Y, Sage EH,
Sasaki T, Sorokin LM, Steiner-Champliaud MF, Sun TT,
Sundarraj N, Timpl R, Virtanen I, Ljubimov AV.
Compositional differences between infant and adult human
corneal basement membranes. Invest Ophthalmol Vis Sci
2007; 48:4989-99. [PMID: 17962449]
37. Määttä M, Heljasvaara R, Pihlajaniemi T, Uusitalo M. Collagen
XVIII/endostatin shows a ubiquitous distribution in human
ocular tissues and endostatin-containing fragments
accumulate in ocular fluid samples. Graefes Arch Clin Exp
Ophthalmol 2007; 245:74-81. [PMID: 16612638]
38. Vanacore R, Ham AJ, Voehler M, Sanders CR, Conrads TP,
Veenstra TD, Sharpless KB, Dawson PE, Hudson BG. A
sulfilimine bond identified in collagen IV. Science 2009;
325:1230-4. [PMID: 19729652]
39. Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann
R, Edgar D, Ekblom P, Engel J, Engvall E, Hohenester E,
Jones JC, Kleinman HK, Marinkovich MP, Martin GR, Mayer
U, Meneguzzi G, Miner JH, Miyazaki K, Patarroyo M,
Paulsson M, Quaranta V, Sanes JR, Sasaki T, Sekiguchi K,
Sorokin LM, Talts JF, Tryggvason K, Uitto J, Virtanen I, von
der Mark K, Wewer UM, Yamada Y, Yurchenco PD. A
simplified laminin nomenclature. Matrix Biol 2005;
24:326-32. [PMID: 15979864]
40. Timpl R, Brown JC. The laminins. Matrix Biol 1994;
14:275-81. [PMID: 7827749]
41. Colognato H, Yurchenco PD. Form and function: the laminin
family of heterotrimers. Dev Dyn 2000; 218:213-34. [PMID:
10842354]
42. Kidd KR, Williams SK. Laminin-5-enriched extracellular
matrix accelerates angiogenesis and neovascularization in
association with ePTFE. J Biomed Mater Res A 2004;
69:294-304. [PMID: 15058002]
43. Davis GE, Senger DR. Endothelial extracellular matrix:
biosynthesis, remodeling, and functions during vascular
morphogenesis and neovessel stabilization. Circ Res 2005;
97:1093-107. [PMID: 16306453]
44. Ports MO, Nagle RB, Pond GD, Cress AE. Extracellular
engagement of alpha6 integrin inhibited urokinase-type
plasminogen activator-mediated cleavage and delayed human
prostate bone metastasis. Cancer Res 2009; 69:5007-14.
[PMID: 19491258]
45. Chan KT, Cortesio CL, Huttenlocher A. Integrins in cell
migration. Methods Enzymol 2007; 426:47-67. [PMID:
17697879]
46. Silva R, D'Amico G, Hodivala-Dilke KM, Reynolds LE.
Integrins: the keys to unlocking angiogenesis. Arterioscler
Thromb Vasc Biol 2008; 28:1703-13. [PMID: 18658045]
47. Wu MH. Endothelial focal adhesions and barrier function. J
Physiol 2005; 569:359-66. [PMID: 16195317]
48. Rupp PA, Little CD. Integrins in vascular development. Circ
Res 2001; 89:566-72. [PMID: 11577021]
Molecular Vision 2011; 17:199-209 <http://www.molvis.org/molvis/v17/a24> © 2011 Molecular Vision
The print version of this article was created on 14 January 2011. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
209
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
